This vial combines two synthetic peptides. CJC-1295 is a 29 amino acid analogue of the first part of growth-hormone-releasing hormone, with four amino acids substituted for stability and a lysine added to carry the DAC (drug affinity complex), a small reactive group that binds serum albumin. It was developed by ConjuChem. The version sold as "CJC-1295 no DAC" is the same peptide without that group.
Ipamorelin is a five amino acid peptide developed at Novo Nordisk in the 1990s that acts on the ghrelin receptor (GHSR-1a). Both have mainly been studied in animal models.
Technical details
| Component | Amount | Formula | Molecular weight | CAS |
|---|---|---|---|---|
| CJC-1295 with DAC | 5 mg | C165H269N47O46 | 3647.2 g/mol | 863288-34-0 |
| Ipamorelin | 5 mg | C38H49N9O5 | 711.9 g/mol | 170851-70-4 |
Research to date: Mostly animal studies; limited human data.
Lab certificate
A third-party certificate of analysis for the current batch will be posted on this page once testing is complete.
Storage
Store the sealed vial in a freezer at around -20 °C, away from light and moisture.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes.
